| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |